ISSN: 1301-2193 E-ISSN: 1308-9846
  • Turkish Journal of
    Endocrinology and Metabolism
CASE REPORT

Retroperitoneal Castleman Disease Mimicking Paraganglioma in a Patient with Klinefelter Syndrome: A Case Report
Klinefelter Sendromlu Bir Hastada Paragangliomayı Taklit Eden Retroperitoneal Castleman Hastalığı: Bir Olgu Sunumu
Doi: 10.25179/tjem.2019-64815 - Makale Dili: EN
Turk J Endocrinol Metab 2019;23:130-134
ABSTRACT
Castleman disease progresses with the enlargement of the affected lymph nodes and represented by a wide range of symptoms. This lymphoproliferative disease rarely affects the retroperitoneum. A patient with Klinefelter syndrome was admitted to our clinic following palpitation and sweat attacks. It was observed that the urinary catecholamine metabolites were elevated and a pararenal mass was found on the left side. The patient was directed to surgery with the paraganglioma pre-diagnosis after further examination. Histopathological examination of the excised mass confirmed the diagnosis of Castleman disease. The urinary catecholamine metabolites returned to near-normal levels at eight weeks after the surgery. We present a case of Castleman disease in a patient with Klinefelter syndrome, imitating paraganglioma as per the clinical, radiological and laboratory findings.
ÖZET
Castleman hastalığı, etkilenen lenf nodunda büyüme ile ortaya çıkar ve birçok farklı semptomla kendini gösterebilir. Bu lenfoproliferatif hastalık, nadiren retroperitoneumu etkilemektedir. Klinefelter sendromlu bir hasta, çarpıntı ve terleme atakları ile kliniğimize başvurdu. İdrar katekolamin metabolitlerinin yükselmiş olduğu gözlenip, sol pararenal bölgede bir kitle saptandı. İleri tetkik edilen hasta paraganglioma ön tanısı ile cerrahiye yönlendirildi. Eksize edilen kitlenin histopatolojik değerlendirme sonucu Castleman hastalığı tanısını doğruladı. Hastanın idrar katekolamin metabolitleri cerrahi sonrası sekizinci haftada normale yakın seviyelere geriledi. Bu çalışmada, Klinefelter sendromlu bir hastada klinik, radyolojik ve laboratuvar bulguları ile paragangliomayı taklit eden bir Castleman hastalığının sunulması amaçlanmıştır.
KAYNAKLAR
  1. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood. 1989;74:1360-1367.
  2. Nishi J, Maruyama I. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular pro-liferation in the affected lymph node. Leuk Lymphoma. 2000;38:387-394. [Crossref] [PubMed]
  3. Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman' s disease: a systematic review of 404 published cases. Ann Surg. 2012;255:677684. [Crossref] [PubMed]
  4. Jiang JP, Shen XF, Du JF, Guan WX. A retrospective study of 34 patients with unicentric and multicentric Castleman’s disease: experience from a single institution. Oncol Lett. 2018;15:2407-2412. [Crossref]
  5. Oksenhendler E, Boutboul D, Fajgenbaum D, Mirouse A, Fieschi C, Malphettes M, Verceliino L, Meignin V, Gérard L, Galicier L. The full spectrum of Castleman disease: 273 patients studied over 20 years. Br J Haematol. 2018;180:206-216. [Crossref] [PubMed]
  6. Keller AR, Hochholzer L, Castleman B. Hyaline vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670-683. [Crossref]
  7. Menke DM, Tiemann M, Camoriano JK, Chang SF, Madan A, Chow M, Habermann TM, Parwarech R. Diagnosis of Castleman’s disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies. Am J Clin Pathol. 1996;105: 268-276. [Crossref] [PubMed]
  8. Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC. Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Haematol. 2016;3:e163-e175. [Crossref]
  9. Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control. 2014;21:266-278. [Crossref] [PubMed]
  10. Wang S, Chen S, Xu J, Cai S. Clinicopathological characteristics of unicentric retroperitoneal Castleman’s disease: a study of 14 cases. World J Surg Oncol. 2016;14:3. [Crossref] [PubMed] [PMC]
  11. Kim KJ, Cho CS, Choi JJ. Pararenal retroperitoneal Castleman’s disease mimicking systemic lupus erythematosus. Int J Rheum Dis. 2010;13:e20-25. [Crossref] [PubMed]
  12. Anderson S, Sasson SC, Lee FJ, Cooper W, Larsen S, Garsia R. Episodic fevers and vasodilatory shock mimicking urosepsis in a patient with HIV-associated multicentric Castleman’s disease: a case report. BMC Infect Dis. 2016;16:53. [Crossref] [PubMed] [PMC]
  13. Tian G, Jing Y, Jiang H, Wang J, Zhang X. Papilledema as the initial presentation of Castleman disease. J Neuroophthalmol. 2014;34:169-172. [Crossref] [PubMed]
  14. Washington T, Vora A, Mihailescu D. A case of hypercalcemia associated with Castleman disease. Endocr Pract. 2010;16:1007-1011. [Crossref] [PubMed]
  15. Kang JM, Lee WJ, Kim WB, Kim TY, Koh JM, Hong SJ, Huh J, Ro JY, Chi HS, Kim MS. Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma. Endocr J. 2005;52:193-198. [Crossref] [PubMed]
  16. Yarman S, Soyluk O, Altunoglu E, Tanakol R. Interleukin-6 producing pheochromocytoma presenting with fever of unknown origin. Clinics (Sao Paulo). 2011;66:1843-1845. [Crossref] [PubMed] [PMC]
  17. Shimizu C, Kubo M, Takano K, Takano A, Kijima H, Saji H, Katsuyama I, Sasano H, Koike T. Interleukin-6 (IL-6) producing pheochromocytoma: direct IL-6 suppression by non-steroidal anti-inflammatory drugs. Clin Endocrinol (Oxf). 2001;54:405-410. [Crossref]
  18. Minetto M, Dovio A, Ventura M, Cappia S, Daffara F, Terzolo M, Angeli A. Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome. J Endocrinol Invest. 2003;26: 453-457. [Crossref] [PubMed]
  19. Tokuda H, Hosoi T, Hayasaka K, Okamura K, Yoshimi N, Kozawa O. Overexpression of protein kinase C-delta plays a crucial role in interleukin-6producing pheochromocytoma presenting with acute inflammatory syndrome: a case report. Horm Metab Res. 2009;41:333-338. [Crossref] [PubMed]
  20. Sokabe A, Mizooka M, Sakemi R, Kobayashi T, Kishikawa N, Yokobayashi K, Kanno K, Tazuma S. Systemic inflammatory syndrome associated with a case of jugular paraganglioma. Intern Med. 2016;55:2105-2108. [Crossref] [PubMed]
  21. Park YT, Park CH, Bae MA, Jung HS, Lee YI, Lim JH, Cha HJ, Seo MJ, Park SH, Choi Y, Kim H, Jo JC. Angioimmunoblastic T-cell lymphoma in a patient with klinefelter syndrome. Am J Case Rep. 2016;17:529534. [Crossref] [PubMed] [PMC]
  22. Simko R, Nagy K, Lombay B, Kiss A, Minik K, Lu kacs VH, Vamosi I. Multicentric Castleman disease and systemic lupus erythematosus phenotype in a boy with Klinefelter syndrome: long-term disease stabilization with interferon therapy. J Pediatr Hematol Oncol. 2000;22:180-183. [Crossref] [PubMed]